Literature DB >> 25882993

Medication-related osteonecrosis of the jaws, stage 0--do we need stage 0 any more?

Hani Mawardi1, Sook-Bin Woo1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25882993     DOI： 10.1016/j.joms.2014.12.028

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  5 in total

1.  DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Authors:  W Wisitrasameewong; M Kajiya; A Movila; S Rittling; T Ishii; M Suzuki; S Matsuda; Y Mazda; M R Torruella; M M Azuma; K Egashira; M O Freire; H Sasaki; C Y Wang; X Han; M A Taubman; T Kawai
Journal:  J Dent Res       Date:  2017-02-15       Impact factor: 6.116

Review 2.  Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.

Authors:  Valesca Sander Koth; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2016-05-31       Impact factor: 2.419

3.  Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study.

Authors:  Takuma Watanabe; Takeshi Yoshida; Sachi Akizuki; Shigeki Yamanaka; Kazumasa Nakao; Shizuko Fukuhara; Keita Asai; Ryuji Uozumi; Kazuhisa Bessho
Journal:  J Bone Miner Metab       Date:  2022-05-09       Impact factor: 2.626

4.  Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?

Authors:  L Bagan; Y Jiménez; M Leopoldo; A Rubert; J Bagan
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-09-01

Review 5.  Review and update on drugs related to the development of osteonecrosis of the jaw.

Authors:  A Eguia; L Bagán-Debón; F Cardona
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.